Seeking Alpha

Vical (VICL -0.3%) says it's inked a worldwide, nonexclusive license of its patented Vaxfectin...

Vical (VICL -0.3%) says it's inked a worldwide, nonexclusive license of its patented Vaxfectin adjuvant to Cyvax, a privately held vaccine development company, for use in malaria vaccines. Financial terms of the agreement were not disclosed.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|